Christopher H. Van Buren

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S notes offering by Sands China Ltd. of $800 million of its 3.800% senior notes due 2026…

Davis Polk advised the representatives of the underwriters in connection with the $70 million follow-on public offering of 5,000,000 shares of common stock of TransMedics Group, Inc…

Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.0 billion aggregate principal amount of its 2.250% notes due 2050…

Davis Polk advised the underwriter in connection with the $59.9 million secondary offering of 2,678,049 shares of common stock of TriState Capital Holdings, Inc. by selling shareholders LM…

Davis Polk advised the underwriters in connection with the SEC-registered notes offering by Las Vegas Sands Corp. of $500 million of its 2.900% senior notes due 2025. Las Vegas Sands…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Steelcase Inc. of $450 million principal…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised FMC Corporation in connection with the separation of its lithium division into a new publicly traded company, to be called Livent Corporation, and advised Livent in…

Davis Polk advised Entera Bio Ltd. on its initial public offering of 1,400,000 ordinary shares and 1,400,000 warrants to purchase up to 700,000 ordinary shares. In addition, Entera Bio Ltd…